Daniel H Li
Overview
Explore the profile of Daniel H Li including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
412
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li D, Lee E, Song C
Allergy Asthma Clin Immunol
. 2022 Jun;
18(1):57.
PMID: 35725661
Background: The mechanism of action behind anaphylactic reactions to the mRNA COVID-19 vaccines remains unknown, but the excipient polyethylene glycol, PEG-2000, has been implicated. Initial recommendations were made for excipient...
2.
Li D, Wong-Pack A, Macikunas A, Kim H
Allergy Asthma Clin Immunol
. 2020 Dec;
16(1):99.
PMID: 33292583
Background: Food protein-induced enterocolitis (FPIES), an entity previously thought to only affect children, has been increasingly described in adults. In this study, we report a Canadian cohort of 19 adolescents...
3.
Gauthier J, Hirayama A, Purushe J, Hay K, Lymp J, Li D, et al.
Blood
. 2020 Feb;
135(19):1650-1660.
PMID: 32076701
We previously reported durable responses in relapsed or refractory (R/R) chronic lymphocytic leukemia (CLL) patients treated with CD19-targeted chimeric antigen receptor-engineered (CD19 CAR) T-cell immunotherapy after ibrutinib failure. Because preclinical...
4.
Li D, Wald R, Blum D, McArthur E, James M, Burns K, et al.
J Crit Care
. 2020 Jan;
56:113-119.
PMID: 31896444
Purpose: Severe acute kidney injury (AKI) is associated with a significant risk of mortality and persistent renal replacement therapy (RRT) dependence. The objective of this study was to develop prediction...
5.
Gardner R, Ceppi F, Rivers J, Annesley C, Summers C, Taraseviciute A, et al.
Blood
. 2019 Nov;
134(24):2149-2158.
PMID: 31697826
Immunotherapy with the adoptive transfer of T cells redirected with CD19-specific chimeric antigen receptors (CARs) for B-lineage acute lymphoblastic leukemia (ALL) can salvage >80% of patients having relapsed/refractory disease. The...
6.
Li D, Whitmore J, Guo W, Ji Y
Clin Cancer Res
. 2016 Oct;
23(1):13-20.
PMID: 27742793
Recent trials of adoptive cell therapy (ACT), such as the chimeric antigen receptor (CAR) T-cell therapy, have demonstrated promising therapeutic effects for cancer patients. A main issue in the product...
7.
Quintana M, Li D, Albertson T, Connor J
Contemp Clin Trials
. 2016 Apr;
48:153-65.
PMID: 27109037
We present a novel Bayesian adaptive phase 1 design to determine the optimal dosing regimen for an adoptive T-cell therapy in a mixed patient population. Our design is motivated by...
8.
Kwan R, Hanada S, Harada M, Strnad P, Li D, Omary M
FASEB J
. 2012 Feb;
26(6):2318-26.
PMID: 22362895
Mallory-Denk bodies (MDBs) are hepatocyte inclusions that are associated with poor liver disease prognosis. The intermediate filament protein keratin 8 (K8) and its cross-linking by transglutaminase-2 (TG2) are essential for...
9.
Zhou Q, Snider N, Liao J, Li D, Hong A, Ku N, et al.
PLoS One
. 2010 Nov;
5(10):e13538.
PMID: 21049038
Background: Keratin polypeptide 19 (K19) is a type I intermediate filament protein that is expressed in stratified and simple-type epithelia. Although K19 is known to be phosphorylated on tyrosine residue(s),...
10.
Guikema J, Schrader C, Brodsky M, Linehan E, Richards A, El Falaky N, et al.
J Immunol
. 2010 May;
184(11):6177-87.
PMID: 20483782
Ig class switch recombination (CSR) occurs in activated mature B cells, and causes an exchange of the IgM isotype for IgG, IgE, or IgA isotypes, which increases the effectiveness of...